-
Featured News /
The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.
-
Statement /
-
Featured News /
September 29 is World Heart Day. For the past six decades, Novartis has been working to advance heart health around the world.
-
Featured News /
We are partnering with the Friedrich Miescher Institute on more than 50 research projects to improve and extend people’s lives.
-
Featured News /
The Novartis Business Development and Licensing team is behind many of the partnerships that fuel our innovation.
-
Featured News /
Seeking to evolve the way it educates and engages with healthcare professionals, Novartis is using digital technology to enhance the quality, transparency and reach of its interactions with the medical community.
-
Featured News /
Patient community representatives call for improved digital health literacy, standardised digital platforms, and co-creation of digital solutions.
-
Featured News /
Fourteen weeks. That’s how many weeks all new Novartis parents will get as minimum paid parental leave, regardless of gender, rolling out from July 1, 2019.
-
Featured News /
Blood diseases place a huge burden on individual patients, their families and on wider society. Yet advances in hematology treatment give so much cause for hope. It’s our responsibility to turn that hope into reality. Hear from five bold advocates who inspire us.
-
Featured News /
Novartis and other industry leaders call for action to address antimicrobial resistance, one of the world’s most serious public health challenges
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 17
- › Next page